J. Quint

First name
J.
Middle name
K.
Last name
Quint
Whittaker, H. R., Bloom, C., Morgan, A., Jarvis, D., Kiddle, S. J., & Quint, J. K. (2020). Accelerated FEV(1) decline and risk of cardiovascular disease and mortality in a primary care population of COPD patients. Eur Respir J. http://doi.org/10.1183/13993003.00918-2020
View
Requena, G., Dedman, D., Quint, J. K., Ghosh, R. E., Williams, R., & Pimenta, J. M. (2021). The Utilization and Safety of Umeclidinium and Umeclidinium/Vilanterol in UK Primary Care: A Retrospective Cohort Study. Int J Chron Obstruct Pulmon Dis. http://doi.org/10.2147/copd.s291931
View
Bloom, C. I., Cabrera, C., Arnetorp, S., Coulton, K., Nan, C., van der Valk, R. J. P., & Quint, J. K. (2020). Asthma-Related Health Outcomes Associated with Short-Acting β(2)-Agonist Inhaler Use: An Observational UK Study as Part of the SABINA Global Program. Adv Ther. http://doi.org/10.1007/s12325-020-01444-5
View
Walker, J. L., Grint, D. J., Strongman, H., Eggo, R. M., Peppa, M., Minassian, C., et al. (2021). UK prevalence of underlying conditions which increase the risk of severe COVID-19 disease: a point prevalence study using electronic health records. BMC Public Health. http://doi.org/10.1186/s12889-021-10427-2
View
Groves, D., Karsanji, U., Evans, R. A., Greening, N., Singh, S. J., Quint, J. K., et al. (2021). Predicting Future Health Risk in COPD: Differential Impact of Disease-Specific and Multi-Morbidity-Based Risk Stratification. Int J Chron Obstruct Pulmon Dis. http://doi.org/10.2147/copd.s303202
View
Wing, K., Williamson, E., Carpenter, J. R., Wise, L., Schneeweiss, S., Smeeth, L., et al. (2021). Medications for chronic obstructive pulmonary disease: a historical non-interventional cohort study with validation against RCT results. Health Technol Assess. http://doi.org/10.3310/hta25510
View
Mansfield, K. E., Mathur, R., Tazare, J., Henderson, A. D., Mulick, A. R., Carreira, H., et al. (2021). Indirect acute effects of the COVID-19 pandemic on physical and mental health in the UK: a population-based study. Lancet Digit Health. http://doi.org/10.1016/s2589-7500(21)00017-0
View
Ngaosuwan, K., Johnston, D. G., Godsland, I. F., Cox, J., Majeed, A., Quint, J. K., et al. (2021). Increased mortality risk in patients with primary and secondary adrenal insufficiency. J Clin Endocrinol Metab. http://doi.org/10.1210/clinem/dgab096
View
Whittaker, H. R., Gulea, C., Koteci, A., Kallis, C., Morgan, A. D., Iwundu, C., et al. (2021). GP consultation rates for sequelae after acute covid-19 in patients managed in the community or hospital in the UK: population based study. Bmj. http://doi.org/10.1136/bmj-2021-065834
View
Ngaosuwan, K., Johnston, D. G., Godsland, I. F., Cox, J., Majeed, A., Quint, J. K., et al. (2021). Full Mortality risk in patients with adrenal insufficiency using Prednisolone or Hydrocortisone: A Retrospective Cohort study. J Clin Endocrinol Metab. http://doi.org/10.1210/clinem/dgab347
View